Early lesion detection with (18)F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer

PURPOSE: Prostate-specific membrane antigen (PSMA) PET/CT is increasingly used in patients with biochemically recurrent prostate cancer (BCR), mostly using gallium-68 ((168)Ga)-labelled radiotracers. Alternatively, fluorine-18 ((18)F)-labelled PSMA tracers are available, such as (18)F-DCFPyL, which...

Descripción completa

Detalles Bibliográficos
Autores principales: Wondergem, M., Jansen, B. H. E., van der Zant, F. M., van der Sluis, T. M., Knol, R. J. J., van Kalmthout, L. W. M., Hoekstra, O. S., van Moorselaar, R. J. A., Oprea-Lager, D. E., Vis, A. N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647179/
https://www.ncbi.nlm.nih.gov/pubmed/31230088
http://dx.doi.org/10.1007/s00259-019-04385-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647179/
https://www.ncbi.nlm.nih.gov/pubmed/31230088
http://dx.doi.org/10.1007/s00259-019-04385-6

Ejemplares similares